Back to top

Image: Bigstock

Nabriva Therapeutics (NBRV) Jumps: Stock Rises 6.7%

Read MoreHide Full Article

Nabriva Therapeutics plc was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.20 to $1.89 in the past one-month time frame.

The company’s Zacks Consensus Estimate for the current quarter has narrowed over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Nabriva Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Nabriva Therapeutics plc Price

A better-ranked stock in the Medical - Biomedical and Genetics industry may consider Acorda Therapeutics, Inc. , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is NBRV going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Published in